Skip to content

Rhenman & Partners Asset Management AB

Follow

13F filer, CIK 1599882, Stockholm, Sweden

Rhenman & Partners Asset Management AB reported $1,059,428,235 across 99 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. Its ten largest share positions make up 25.08% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001213900-26-088652

Period
2026-06-30
Reported value
$1.06B
Holdings
99
Top 10 weight
25.08%
New
21
Sold out
8

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AZNnew+151,500$28.5M
MRKnew+213,500$27.4M
UNHadded+48,100$20M
JNJnew+72,500$18.4M
CNCnew+244,000$15.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
LLYreduced-11,400-$13.7M
REGNreduced-20,710-$12.9M
VEEVreduced-68,000-$12.1M
ADPTexited-720,000-$9.99M
IQVexited-53,000-$9.04M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001213900-26-088652, largest first. % of portfolio is the value over $1,059,428,235, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 72,700 shares; 2024Q4: 60,530 shares; 2025Q1: 77,430 shares; 2025Q2: 30,430 shares; 2025Q3: 62,530 shares; 2025Q4: 54,900 shares; 2026Q1: 45,500 shares; 2026Q2: 93,600 shares 93,600$38.9M3.67%+48,100Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 184,000 shares; 2024Q4: 267,500 shares; 2025Q1: 235,862 shares; 2025Q2: 295,362 shares; 2025Q3: 277,362 shares; 2025Q4: 335,500 shares; 2026Q1: 336,500 shares; 2026Q2: 279,374 shares 279,374$28.9M2.73%-57,126Timeline
AZNASTRAZENECA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 151,500 shares 151,500$28.5M2.69%newTimeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 241,000 shares; 2024Q4: 277,500 shares; 2025Q1: 33,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 213,500 shares 213,500$27.4M2.59%newTimeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 47,500 shares; 2024Q4: 45,450 shares; 2025Q1: 41,750 shares; 2025Q2: 57,870 shares; 2025Q3: 53,420 shares; 2025Q4: 42,220 shares; 2026Q1: 33,715 shares; 2026Q2: 22,315 shares 22,315$26.8M2.53%-11,400Timeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 177,000 shares; 2024Q4: 124,150 shares; 2025Q1: 88,650 shares; 2025Q2: 69,375 shares; 2025Q3: 130,375 shares; 2025Q4: 110,575 shares; 2026Q1: 71,575 shares; 2026Q2: 96,775 shares 96,775$24.4M2.3%+25,200Timeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,977,363 shares; 2024Q4: 1,761,192 shares; 2025Q1: 1,337,284 shares; 2025Q2: 1,287,284 shares; 2025Q3: 1,479,284 shares; 2025Q4: 1,009,450 shares; 2026Q1: 1,053,450 shares; 2026Q2: 997,083 shares 997,083$23.7M2.24%-56,367Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 55,000 shares; 2025Q3: 155,000 shares; 2025Q4: 193,500 shares; 2026Q1: 163,000 shares; 2026Q2: 260,000 shares 260,000$23.5M2.22%+97,000Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 366,500 shares; 2024Q4: 255,500 shares; 2025Q1: 233,500 shares; 2025Q2: 168,150 shares; 2025Q3: 80,150 shares; 2025Q4: 126,150 shares; 2026Q1: 167,750 shares; 2026Q2: 178,250 shares 178,250$22.5M2.13%+10,500Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 93,000 shares; 2024Q4: 145,500 shares; 2025Q1: 124,300 shares; 2025Q2: 109,030 shares; 2025Q3: 95,030 shares; 2025Q4: 74,030 shares; 2026Q1: 75,890 shares; 2026Q2: 87,440 shares 87,440$21.1M1.99%+11,550Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 67,100 shares; 2024Q4: 123,700 shares; 2025Q1: 49,500 shares; 2025Q2: 12,000 shares; 2025Q3: 55,000 shares; 2025Q4: 92,350 shares; 2026Q1: 109,100 shares; 2026Q2: 94,850 shares 94,850$20.5M1.93%-14,250Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 23,000 shares; 2024Q4: 22,500 shares; 2025Q1: not reported; 2025Q2: 11,500 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 47,800 shares; 2026Q2: 65,000 shares 65,000$20.5M1.93%+17,200Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 590,000 shares; 2024Q4: 444,000 shares; 2025Q1: 300,000 shares; 2025Q2: 296,000 shares; 2025Q3: 438,000 shares; 2025Q4: 431,207 shares; 2026Q1: 625,000 shares; 2026Q2: 450,500 shares 450,500$19.2M1.81%-174,500Timeline
JNJJOHNSON & JOHNSONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 72,500 shares 72,500$18.4M1.74%newTimeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 80,000 shares; 2026Q1: 145,000 shares; 2026Q2: 115,000 shares 115,000$17.3M1.63%-30,000Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 39,000 shares; 2024Q4: 43,457 shares; 2025Q1: 31,750 shares; 2025Q2: 27,700 shares; 2025Q3: 36,100 shares; 2025Q4: 61,400 shares; 2026Q1: 48,100 shares; 2026Q2: 27,390 shares 27,390$17.1M1.61%-20,710Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 111,000 shares; 2024Q4: 36,531 shares; 2025Q1: 270,000 shares; 2025Q2: 235,000 shares; 2025Q3: 230,000 shares; 2025Q4: 210,000 shares; 2026Q1: 84,000 shares; 2026Q2: 119,000 shares 119,000$16.6M1.57%+35,000Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 364,500 shares; 2024Q4: 250,623 shares; 2025Q1: 265,000 shares; 2025Q2: 149,650 shares; 2025Q3: 186,650 shares; 2025Q4: 215,000 shares; 2026Q1: 207,000 shares; 2026Q2: 290,500 shares 290,500$16.6M1.57%+83,500Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 300,000 shares; 2024Q4: 290,000 shares; 2025Q1: 249,336 shares; 2025Q2: 185,000 shares; 2025Q3: 347,500 shares; 2025Q4: 537,500 shares; 2026Q1: 313,500 shares; 2026Q2: 684,250 shares 684,250$16.6M1.57%+370,750Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 231,000 shares; 2024Q4: 123,410 shares; 2025Q1: 138,500 shares; 2025Q2: 57,500 shares; 2025Q3: 31,000 shares; 2025Q4: 40,500 shares; 2026Q1: 51,600 shares; 2026Q2: 61,050 shares 61,050$16.6M1.56%+9,450Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 105,000 shares; 2024Q4: 73,755 shares; 2025Q1: 73,755 shares; 2025Q2: 65,755 shares; 2025Q3: 56,255 shares; 2025Q4: 106,255 shares; 2026Q1: 92,605 shares; 2026Q2: 139,205 shares 139,205$16.3M1.54%+46,600Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 129,513 shares; 2024Q4: 61,500 shares; 2025Q1: 185,500 shares; 2025Q2: 175,435 shares; 2025Q3: 131,885 shares; 2025Q4: 113,585 shares; 2026Q1: 159,760 shares; 2026Q2: 151,960 shares 151,960$16.2M1.53%-7,800Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 221,400 shares; 2024Q4: 197,700 shares; 2025Q1: 126,700 shares; 2025Q2: 136,429 shares; 2025Q3: 58,429 shares; 2025Q4: 76,504 shares; 2026Q1: 54,000 shares; 2026Q2: 85,200 shares 85,200$15.9M1.5%+31,200Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 25,100 shares; 2024Q4: 15,640 shares; 2025Q1: 12,640 shares; 2025Q2: 11,140 shares; 2025Q3: 30,040 shares; 2025Q4: 33,640 shares; 2026Q1: 41,340 shares; 2026Q2: 31,580 shares 31,580$15.8M1.49%-9,760Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 116,982 shares; 2024Q4: 195,482 shares; 2025Q1: 126,000 shares; 2025Q2: 99,757 shares; 2025Q3: 170,000 shares; 2025Q4: 46,231 shares; 2026Q1: not reported; 2026Q2: 244,000 shares 244,000$15.7M1.48%newTimeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 122,600 shares; 2024Q4: 122,600 shares; 2025Q1: 109,600 shares; 2025Q2: 90,800 shares; 2025Q3: 172,800 shares; 2025Q4: 114,800 shares; 2026Q1: 63,800 shares; 2026Q2: 63,050 shares 63,050$15.4M1.46%-750Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 83,302 shares; 2024Q4: 63,952 shares; 2025Q1: 41,952 shares; 2025Q2: 121,452 shares; 2025Q3: 134,452 shares; 2025Q4: 99,052 shares; 2026Q1: 18,052 shares; 2026Q2: 80,252 shares 80,252$15.3M1.44%+62,200Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 47,750 shares; 2024Q4: 50,000 shares; 2025Q1: 66,750 shares; 2025Q2: 61,455 shares; 2025Q3: 46,955 shares; 2025Q4: 34,255 shares; 2026Q1: 43,485 shares; 2026Q2: 30,685 shares 30,685$15.2M1.44%-12,800Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,290,000 shares; 2025Q2: 1,250,763 shares; 2025Q3: 1,250,763 shares; 2025Q4: 1,238,625 shares; 2026Q1: 1,438,625 shares; 2026Q2: 1,538,625 shares 1,538,625$15.2M1.43%+100,000Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 71,750 shares; 2024Q4: 100,317 shares; 2025Q1: 89,817 shares; 2025Q2: 149,217 shares; 2025Q3: 114,717 shares; 2025Q4: 125,491 shares; 2026Q1: 100,841 shares; 2026Q2: 85,841 shares 85,841$14.5M1.37%-15,000Timeline
PNTGPENNANT GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 357,346 shares; 2026Q1: 275,399 shares; 2026Q2: 371,471 shares 371,471$13.7M1.3%+96,072Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 63,000 shares; 2024Q4: 64,000 shares; 2025Q1: 51,500 shares; 2025Q2: 44,350 shares; 2025Q3: 48,500 shares; 2025Q4: 48,000 shares; 2026Q1: 36,846 shares; 2026Q2: 34,500 shares 34,500$13.7M1.3%-2,346Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 50,500 shares; 2024Q4: 23,150 shares; 2025Q1: 48,950 shares; 2025Q2: 44,650 shares; 2025Q3: 22,500 shares; 2025Q4: 15,000 shares; 2026Q1: 32,300 shares; 2026Q2: 34,900 shares 34,900$13.5M1.27%+2,600Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 53,000 shares; 2025Q3: 53,000 shares; 2025Q4: 190,000 shares; 2026Q1: 155,000 shares; 2026Q2: 164,000 shares 164,000$13.5M1.27%+9,000Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 45,150 shares; 2024Q4: 53,750 shares; 2025Q1: 32,375 shares; 2025Q2: 49,375 shares; 2025Q3: 62,375 shares; 2025Q4: 63,375 shares; 2026Q1: 52,375 shares; 2026Q2: 46,778 shares 46,778$13.2M1.25%-5,597Timeline
CRLCHARLES RIV LABS INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 37,500 shares; 2024Q4: 14,850 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 22,000 shares; 2026Q1: 26,000 shares; 2026Q2: 57,200 shares 57,200$13M1.22%+31,200Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 127,500 shares; 2024Q4: 82,000 shares; 2025Q1: 39,500 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,000 shares; 2026Q1: 255,500 shares; 2026Q2: 343,800 shares 343,800$12.8M1.21%+88,300Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 30,117 shares; 2024Q4: 34,117 shares; 2025Q1: 47,217 shares; 2025Q2: 27,717 shares; 2025Q3: 26,600 shares; 2025Q4: 25,600 shares; 2026Q1: 16,850 shares; 2026Q2: 16,550 shares 16,550$12.5M1.18%-300Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 259,500 shares; 2024Q4: 232,000 shares; 2025Q1: 433,000 shares; 2025Q2: 574,000 shares; 2025Q3: 574,000 shares; 2025Q4: 487,000 shares; 2026Q1: 379,250 shares; 2026Q2: 560,250 shares 560,250$12.2M1.16%+181,000Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares; 2025Q4: 198,000 shares; 2026Q1: 50,000 shares; 2026Q2: 165,896 shares 165,896$11.6M1.09%+115,896Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 368,000 shares; 2024Q4: 269,500 shares; 2025Q1: 255,000 shares; 2025Q2: 179,500 shares; 2025Q3: 205,000 shares; 2025Q4: 296,000 shares; 2026Q1: 90,000 shares; 2026Q2: 145,000 shares 145,000$11.3M1.07%+55,000Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 165,000 shares; 2025Q4: 142,571 shares; 2026Q1: 263,071 shares; 2026Q2: 416,371 shares 416,371$11.2M1.06%+153,300Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,371,147 shares; 2024Q4: 1,362,421 shares; 2025Q1: 1,022,743 shares; 2025Q2: 312,092 shares; 2025Q3: not reported; 2025Q4: 260,000 shares; 2026Q1: 660,000 shares; 2026Q2: 392,000 shares 392,000$11.2M1.06%-268,000Timeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 613,500 shares; 2024Q4: 595,000 shares; 2025Q1: 411,000 shares; 2025Q2: 344,000 shares; 2025Q3: 258,500 shares; 2025Q4: 206,500 shares; 2026Q1: 233,000 shares; 2026Q2: 197,000 shares 197,000$11M1.04%-36,000Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 87,000 shares; 2024Q4: not reported; 2025Q1: 155,000 shares; 2025Q2: 159,500 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 160,000 shares 160,000$10.8M1.02%newTimeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 55,000 shares; 2024Q4: 41,900 shares; 2025Q1: 41,500 shares; 2025Q2: 66,500 shares; 2025Q3: 83,000 shares; 2025Q4: 99,000 shares; 2026Q1: 7,500 shares; 2026Q2: 63,000 shares 63,000$10.6M1%+55,500Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 119,300 shares 119,300$10.6M1%newTimeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 460,000 shares; 2024Q4: 460,000 shares; 2025Q1: 460,000 shares; 2025Q2: 460,000 shares; 2025Q3: 460,000 shares; 2025Q4: 460,000 shares; 2026Q1: 360,000 shares; 2026Q2: 566,000 shares 566,000$10.6M1%+206,000Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 144,500 shares; 2026Q1: 144,500 shares; 2026Q2: 128,000 shares 128,000$10.4M0.98%-16,500Timeline
AAGILENT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 25,000 shares; 2026Q2: 75,000 shares 75,000$9.96M0.94%+50,000Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 59,000 shares; 2026Q2: 141,250 shares 141,250$9.86M0.93%+82,250Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 133,000 shares; 2024Q4: 77,999 shares; 2025Q1: 39,000 shares; 2025Q2: 39,000 shares; 2025Q3: 94,000 shares; 2025Q4: 133,250 shares; 2026Q1: 133,250 shares; 2026Q2: 185,250 shares 185,250$9.71M0.92%+52,000Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 135,000 shares; 2024Q4: 128,000 shares; 2025Q1: 52,000 shares; 2025Q2: 58,500 shares; 2025Q3: 98,500 shares; 2025Q4: not reported; 2026Q1: 112,000 shares; 2026Q2: 96,000 shares 96,000$8.71M0.82%-16,000Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 150,000 shares; 2024Q4: 114,000 shares; 2025Q1: 126,627 shares; 2025Q2: 126,627 shares; 2025Q3: 173,627 shares; 2025Q4: 98,627 shares; 2026Q1: 81,627 shares; 2026Q2: 86,127 shares 86,127$8.4M0.79%+4,500Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 445,000 shares; 2024Q4: 420,345 shares; 2025Q1: 448,000 shares; 2025Q2: 190,000 shares; 2025Q3: 390,000 shares; 2025Q4: 611,000 shares; 2026Q1: 475,000 shares; 2026Q2: 345,000 shares 345,000$7.79M0.74%-130,000Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 70,000 shares; 2025Q2: 135,100 shares; 2025Q3: 180,100 shares; 2025Q4: 147,600 shares; 2026Q1: 128,100 shares; 2026Q2: 145,100 shares 145,100$7.79M0.74%+17,000Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 80,000 shares 80,000$7.61M0.72%newTimeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 61,000 shares; 2024Q4: 56,000 shares; 2025Q1: 37,400 shares; 2025Q2: 136,400 shares; 2025Q3: 119,400 shares; 2025Q4: 146,263 shares; 2026Q1: 56,263 shares; 2026Q2: 74,263 shares 74,263$7.51M0.71%+18,000Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 45,000 shares; 2025Q2: 45,000 shares; 2025Q3: 207,000 shares; 2025Q4: 364,000 shares; 2026Q1: 239,500 shares; 2026Q2: 384,800 shares 384,800$7.49M0.71%+145,300Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,052,500 shares; 2024Q4: 1,235,448 shares; 2025Q1: 647,827 shares; 2025Q2: 647,827 shares; 2025Q3: 1,097,827 shares; 2025Q4: 1,595,327 shares; 2026Q1: 2,055,327 shares; 2026Q2: 1,705,327 shares 1,705,327$7.09M0.67%-350,000Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 268,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 81,600 shares; 2026Q1: 90,600 shares; 2026Q2: 91,100 shares 91,100$6.79M0.64%+500Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 166,526 shares; 2024Q4: 314,526 shares; 2025Q1: 195,000 shares; 2025Q2: 250,000 shares; 2025Q3: 490,000 shares; 2025Q4: 872,000 shares; 2026Q1: 271,500 shares; 2026Q2: 591,500 shares 591,500$6.49M0.61%+320,000Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 40,000 shares; 2024Q4: 57,000 shares; 2025Q1: 61,000 shares; 2025Q2: 46,000 shares; 2025Q3: 58,000 shares; 2025Q4: 61,000 shares; 2026Q1: 14,000 shares; 2026Q2: 42,000 shares 42,000$6.39M0.6%+28,000Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 349,000 shares 349,000$6.39M0.6%newTimeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 17,000 shares; 2024Q4: 23,750 shares; 2025Q1: 17,750 shares; 2025Q2: 12,750 shares; 2025Q3: 11,750 shares; 2025Q4: 25,000 shares; 2026Q1: 16,675 shares; 2026Q2: 16,325 shares 16,325$6.07M0.57%-350Timeline
STVNSTEVANATO GROUP S P AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 51,000 shares; 2025Q4: 147,025 shares; 2026Q1: 274,676 shares; 2026Q2: 305,972 shares 305,972$5.53M0.52%+31,296Timeline
ASTHASTRANA HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 80,000 shares; 2025Q1: 150,000 shares; 2025Q2: 190,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 118,888 shares 118,888$5.52M0.52%newTimeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 55,000 shares; 2025Q3: 94,000 shares; 2025Q4: not reported; 2026Q1: 27,000 shares; 2026Q2: 22,500 shares 22,500$5.35M0.5%-4,500Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 50,350 shares; 2024Q4: 17,000 shares; 2025Q1: 48,197 shares; 2025Q2: 51,197 shares; 2025Q3: 31,875 shares; 2025Q4: 45,675 shares; 2026Q1: 34,465 shares; 2026Q2: 17,200 shares 17,200$5.18M0.49%-17,265Timeline
MOHMOLINA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 29,600 shares; 2024Q4: 34,200 shares; 2025Q1: 68,200 shares; 2025Q2: 22,200 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 21,857 shares 21,857$5M0.47%newTimeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 102,500 shares; 2024Q4: 90,000 shares; 2025Q1: 100,000 shares; 2025Q2: 85,000 shares; 2025Q3: 216,288 shares; 2025Q4: 83,000 shares; 2026Q1: 160,000 shares; 2026Q2: 128,000 shares 128,000$4.99M0.47%-32,000Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 41,685 shares; 2024Q4: 78,385 shares; 2025Q1: 28,200 shares; 2025Q2: 32,000 shares; 2025Q3: 46,500 shares; 2025Q4: 38,650 shares; 2026Q1: 8,000 shares; 2026Q2: 17,400 shares 17,400$4.8M0.45%+9,400Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 195,000 shares; 2024Q4: 212,500 shares; 2025Q1: 81,000 shares; 2025Q2: 182,000 shares; 2025Q3: 310,000 shares; 2025Q4: 158,500 shares; 2026Q1: 92,900 shares; 2026Q2: 59,900 shares 59,900$4.75M0.45%-33,000Timeline
AMNAMN HEALTHCARE SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 144,466 shares 144,466$4.68M0.44%newTimeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 199,000 shares; 2026Q2: 179,000 shares 179,000$4.6M0.43%-20,000Timeline
MEDPMEDPACE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,500 shares; 2024Q4: 6,800 shares; 2025Q1: 3,800 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 8,500 shares 8,500$4.5M0.42%newTimeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 15,300 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,250 shares; 2025Q4: 19,550 shares; 2026Q1: 24,050 shares; 2026Q2: 8,050 shares 8,050$4.32M0.41%-16,000Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 3,000 shares; 2024Q4: 3,000 shares; 2025Q1: 4,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 36,000 shares; 2026Q1: 15,200 shares; 2026Q2: 11,900 shares 11,900$4.31M0.41%-3,300Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 87,500 shares; 2026Q2: 97,100 shares 97,100$4.27M0.4%+9,600Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 15,000 shares 15,000$4M0.38%newTimeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 228,000 shares; 2024Q4: 115,000 shares; 2025Q1: 236,000 shares; 2025Q2: 170,000 shares; 2025Q3: 237,000 shares; 2025Q4: 327,500 shares; 2026Q1: 50,000 shares; 2026Q2: 54,000 shares 54,000$3.87M0.37%+4,000Timeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 342,566 shares; 2026Q2: 178,566 shares 178,566$3.67M0.35%-164,000Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 62,000 shares 62,000$3.42M0.32%newTimeline
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,000 shares; 2025Q3: 117,000 shares; 2025Q4: 117,000 shares; 2026Q1: 70,000 shares; 2026Q2: 70,000 shares 70,000$3.11M0.29%0Timeline
VEEVVEEVA SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 85,300 shares; 2026Q2: 17,300 shares 17,300$3.07M0.29%-68,000Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 88,150 shares 88,150$2.62M0.25%newTimeline
STESTERIS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 6,000 shares; 2026Q1: 11,500 shares; 2026Q2: 11,500 shares 11,500$2.42M0.23%0Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 202,000 shares; 2025Q4: 265,000 shares; 2026Q1: 305,000 shares; 2026Q2: 225,000 shares 225,000$2.21M0.21%-80,000Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,000 shares; 2025Q4: 216,000 shares; 2026Q1: 83,000 shares; 2026Q2: 64,500 shares 64,500$2.11M0.2%-18,500Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 35,000 shares; 2024Q4: 35,000 shares; 2025Q1: 35,000 shares; 2025Q2: 35,000 shares; 2025Q3: 81,000 shares; 2025Q4: 139,000 shares; 2026Q1: 28,000 shares; 2026Q2: 33,250 shares 33,250$2.01M0.19%+5,250Timeline
DOCSDOXIMITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 21,000 shares; 2025Q3: 136,000 shares; 2025Q4: 372,750 shares; 2026Q1: 183,808 shares; 2026Q2: 76,107 shares 76,107$1.58M0.15%-107,701Timeline
PRVAPRIVIA HEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 95,189 shares; 2024Q4: 121,189 shares; 2025Q1: 98,189 shares; 2025Q2: 91,189 shares; 2025Q3: 194,189 shares; 2025Q4: 125,000 shares; 2026Q1: not reported; 2026Q2: 50,000 shares 50,000$1.29M0.12%newTimeline
NVCRNOVOCURE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 70,000 shares; 2026Q2: 70,000 shares 70,000$1.06M0.1%0Timeline
MMEDMINIMED GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 55,000 shares 55,000$822K0.08%newTimeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,000 shares; 2025Q4: 20,000 shares; 2026Q1: 70,000 shares; 2026Q2: 85,000 shares 85,000$735K0.07%+15,000Timeline
AGLAGILON HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,000 shares 5,000$536K0.05%newTimeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 8,500 shares 8,500$326K0.03%newTimeline
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 20,000 shares 20,000$302K0.03%newTimeline
TGTXTG THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 171,500 shares; 2024Q4: 262,500 shares; 2025Q1: 177,500 shares; 2025Q2: 115,000 shares; 2025Q3: 93,000 shares; 2025Q4: 73,250 shares; 2026Q1: not reported; 2026Q2: 5,000 shares 5,000$275K0.03%newTimeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ADPTADAPTIVE BIOTECHNOLOGIES COR720,000$9.99Mshares
IQVIQVIA HLDGS INC53,000$9.04Mshares
NUVLNUVALENT INC81,200$8.32Mshares
APGEAPOGEE THERAPEUTICS INC75,000$6.31Mshares
ASNDASCENDIS PHARMA A/S15,000$3.43Mshares
ESPRESPERION THERAPEUTICS INC NE985,000$2.7Mshares
IMCRIMMUNOCORE HLDGS PLC85,724$2.58Mshares
CMPXCOMPASS THERAPEUTICS INC115,113$609Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001213900-26-088652 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001213900-26-088652 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0001213900-26-056196 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0001213900-26-015821 Quarter ended 2025-12-312026-02-13acceptance time not in the bulk data set
13F-HR 0001213900-25-109534 Quarter ended 2025-09-302025-11-13acceptance time not in the bulk data set
13F-HR 0001213900-25-075249 Quarter ended 2025-06-302025-08-13acceptance time not in the bulk data set
13F-HR 0001213900-25-042939 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0001213900-25-013150 Quarter ended 2024-12-312025-02-13acceptance time not in the bulk data set
13F-HR 0001213900-24-097092 Quarter ended 2024-09-302024-11-13acceptance time not in the bulk data set
13F-HR 0001213900-24-067896 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR 0001213900-24-042547 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0001213900-24-012894 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR/A 0001213900-23-085459 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-HR 0001213900-23-085253 Quarter ended 2023-09-302023-11-09acceptance time not in the bulk data set
13F-HR 0001213900-23-065840 Quarter ended 2023-06-302023-08-11acceptance time not in the bulk data set
13F-HR 0001213900-23-038637 Quarter ended 2023-03-312023-05-12acceptance time not in the bulk data set
13F-HR 0001213900-23-010457 Quarter ended 2022-12-312023-02-13acceptance time not in the bulk data set
13F-HR 0001213900-22-072302 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001213900-22-047070 Quarter ended 2022-06-302022-08-12acceptance time not in the bulk data set
13F-HR 0001213900-22-026487 Quarter ended 2022-03-312022-05-13acceptance time not in the bulk data set
13F-HR 0001213900-22-006636 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0001213900-21-058306 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0001213900-21-042239 Quarter ended 2021-06-302021-08-13acceptance time not in the bulk data set
13F-HR 0001213900-21-026215 Quarter ended 2021-03-312021-05-14acceptance time not in the bulk data set
13F-HR 0001213900-21-002698 Quarter ended 2020-12-312021-01-19acceptance time not in the bulk data set
13F-HR 0001213900-20-031038 Quarter ended 2020-09-302020-10-13acceptance time not in the bulk data set
13F-HR 0001213900-20-017623 Quarter ended 2020-06-302020-07-16acceptance time not in the bulk data set
13F-HR 0001213900-20-009314 Quarter ended 2020-03-312020-04-16acceptance time not in the bulk data set
13F-HR 0001213900-20-001297 Quarter ended 2019-12-312020-01-17acceptance time not in the bulk data set
13F-HR 0001213900-19-020405 Quarter ended 2019-09-302019-10-16acceptance time not in the bulk data set
13F-HR 0001213900-19-013307 Quarter ended 2019-06-302019-07-22acceptance time not in the bulk data set
13F-HR 0001213900-19-006146 Quarter ended 2019-03-312019-04-11acceptance time not in the bulk data set
13F-HR 0001213900-19-001686 Quarter ended 2018-12-312019-02-05acceptance time not in the bulk data set
13F-HR 0001415889-18-001462 Quarter ended 2018-09-302018-10-03acceptance time not in the bulk data set
13F-HR 0001415889-18-001149 Quarter ended 2018-06-302018-07-20acceptance time not in the bulk data set
13F-HR 0001415889-18-000595 Quarter ended 2018-03-312018-04-11acceptance time not in the bulk data set
13F-HR 0001415889-18-000085 Quarter ended 2017-12-312018-01-19acceptance time not in the bulk data set
13F-HR 0001415889-17-001660 Quarter ended 2017-09-302017-10-13acceptance time not in the bulk data set
13F-HR 0001415889-17-001145 Quarter ended 2017-06-302017-07-11acceptance time not in the bulk data set
13F-HR 0001415889-17-000651 Quarter ended 2017-03-312017-04-19acceptance time not in the bulk data set
13F-HR 0001415889-17-000078 Quarter ended 2016-12-312017-01-13acceptance time not in the bulk data set
13F-HR 0001415889-16-007347 Quarter ended 2016-09-302016-11-08acceptance time not in the bulk data set
13F-HR 0001415889-16-006640 Quarter ended 2016-06-302016-08-01acceptance time not in the bulk data set
13F-HR 0001415889-16-005562 Quarter ended 2016-03-312016-04-19acceptance time not in the bulk data set
13F-HR 0001415889-16-004481 Quarter ended 2015-12-312016-01-19acceptance time not in the bulk data set
13F-HR 0001415889-15-003497 Quarter ended 2015-09-302015-10-26acceptance time not in the bulk data set
13F-HR 0001415889-15-002492 Quarter ended 2015-06-302015-07-30acceptance time not in the bulk data set
13F-HR 0001415889-15-001643 Quarter ended 2015-03-312015-05-13acceptance time not in the bulk data set
13F-HR 0001415889-15-000450 Quarter ended 2014-12-312015-02-09acceptance time not in the bulk data set
13F-HR 0001415889-14-003285 Quarter ended 2014-09-302014-11-03acceptance time not in the bulk data set
13F-HR 0001415889-14-002277 Quarter ended 2014-06-302014-07-31acceptance time not in the bulk data set
13F-HR 0001521536-14-000049 Quarter ended 2014-03-312014-05-14acceptance time not in the bulk data set
13F-HR 0001521536-14-000045 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set